An LONP1 activator effectively suppressed TGF‐β1‐induced fibrotic responses in mPTCs and attenuated UUO and UIRI‐induced renal fibrosis and mitochondrial dysfunction. This evidence concerns the gene TGFB1 and renal fibrosis.